143 related articles for article (PubMed ID: 20113402)
1. Neurofibromatosis 2 with peripheral neuropathies: Electrophysiological, pathological and genetic studies of a Taiwanese family.
Kuo HC; Chen SR; Jung SM; Wu Chou YH; Huang CC; Chuang WL; Wei KC; Ro LS
Neuropathology; 2010 Oct; 30(5):515-23. PubMed ID: 20113402
[TBL] [Abstract][Full Text] [Related]
2. Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens.
Hagel C; Lindenau M; Lamszus K; Kluwe L; Stavrou D; Mautner VF
Acta Neuropathol; 2002 Aug; 104(2):179-87. PubMed ID: 12111361
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2.
Sperfeld AD; Hein C; Schröder JM; Ludolph AC; Hanemann CO
Brain; 2002 May; 125(Pt 5):996-1004. PubMed ID: 11960890
[TBL] [Abstract][Full Text] [Related]
4. Schwann cell proliferation as the cause of peripheral neuropathy in neurofibromatosis-2.
Iwata A; Kunimoto M; Inoue K
J Neurol Sci; 1998 Apr; 156(2):201-4. PubMed ID: 9588858
[TBL] [Abstract][Full Text] [Related]
5. Role of NF2 haploinsufficiency in NF2-associated polyneuropathy.
Hanemann CO; Diebold R; Kaufmann D
Brain Pathol; 2007 Oct; 17(4):371-6. PubMed ID: 17655741
[TBL] [Abstract][Full Text] [Related]
6. Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2.
Gijtenbeek JM; Gabreëls-Festen AA; Lammens M; Zwarts MJ; van Engelen BG
Neurology; 2001 Jun; 56(12):1766-8. PubMed ID: 11425952
[TBL] [Abstract][Full Text] [Related]
7. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
Stemmer-Rachamimov AO; Ino Y; Lim ZY; Jacoby LB; MacCollin M; Gusella JF; Ramesh V; Louis DN
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1164-7. PubMed ID: 9862639
[TBL] [Abstract][Full Text] [Related]
8. [Mutation analysis of NF2 gene and clinical investigation in a Chinese family with neurofibromatosis type II].
Cui YX; Xia XY; Huang TT; Wei L; Fan XB; Yao B; Ge YF; Li XJ; Huang YF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Dec; 27(6):688-91. PubMed ID: 21154335
[TBL] [Abstract][Full Text] [Related]
9. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.
MacCollin M; Mohney T; Trofatter J; Wertelecki W; Ramesh V; Gusella J
JAMA; 1993 Nov; 270(19):2316-20. PubMed ID: 8230593
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic variability in two families with novel splice-site and frameshift NF2 mutations.
Mautner VF; Baser ME; Kluwe L
Hum Genet; 1996 Aug; 98(2):203-6. PubMed ID: 8698343
[TBL] [Abstract][Full Text] [Related]
11. CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressor.
MacCollin M
Brain Dev; 1995; 17(4):231-8. PubMed ID: 7503383
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of neurofibromatosis 2 (NF2) missense mutations.
Gutmann DH; Hirbe AC; Haipek CA
Hum Mol Genet; 2001 Jul; 10(14):1519-29. PubMed ID: 11448944
[TBL] [Abstract][Full Text] [Related]
13. Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.
Truong K; Ahmad I; Jason Clark J; Seline A; Bertroche T; Mostaert B; Van Daele DJ; Hansen MR
Neuroscience; 2018 Mar; 374():205-213. PubMed ID: 29408605
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of patients with neurofibromatosis 2.
MacCollin M; Ramesh V; Jacoby LB; Louis DN; Rubio MP; Pulaski K; Trofatter JA; Short MP; Bove C; Eldridge R
Am J Hum Genet; 1994 Aug; 55(2):314-20. PubMed ID: 7913580
[TBL] [Abstract][Full Text] [Related]
16. [Phenotype-genotype study in 154 French NF2 mutation carriers].
Demange L; De Moncuit C; Thomas G; Olschwang S
Rev Neurol (Paris); 2007 Nov; 163(11):1031-8. PubMed ID: 18033041
[TBL] [Abstract][Full Text] [Related]
17. Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.
Schulz A; Baader SL; Niwa-Kawakita M; Jung MJ; Bauer R; Garcia C; Zoch A; Schacke S; Hagel C; Mautner VF; Hanemann CO; Dun XP; Parkinson DB; Weis J; Schröder JM; Gutmann DH; Giovannini M; Morrison H
Nat Neurosci; 2013 Apr; 16(4):426-33. PubMed ID: 23455610
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy.
Bäumer P; Mautner VF; Bäumer T; Schuhmann MU; Tatagiba M; Heiland S; Kaestel T; Bendszus M; Pham M
J Neurol; 2013 Jan; 260(1):38-46. PubMed ID: 22760943
[TBL] [Abstract][Full Text] [Related]
19. Focal amyotrophy in neurofibromatosis 2.
Trivedi R; Byrne J; Huson SM; Donaghy M
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):257-61. PubMed ID: 10896706
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of the NF2 gene in Korean patients with neurofibromatosis type 2: a report of four novel mutations.
Seong MW; Yeo IK; Cho SI; Park CK; Kim SK; Paek SH; Kim DG; Jung HW; Park H; Kim SY; Kim JY; Park SS
Korean J Lab Med; 2010 Apr; 30(2):190-4. PubMed ID: 20445339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
